Potent bicyclic lactam inhibitors of thrombin: Part I: P3 modifications
- 1 November 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (22) , 3193-3198
- https://doi.org/10.1016/s0960-894x(98)00550-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- BCH-2763, a Novel Potent Parenteral Thrombin Inhibitor, Is an Effective Antithrombotic Agent in Rodent Models of Arterial and Venous Thrombosis – Comparisons with Heparin, r-Hirudin, Hirulog, Inogatran and ArgatrobanThrombosis and Haemostasis, 1998
- New routes to conformationally restricted peptide building blocks: a convenient preparation of bicyclic piperazinone derivativesBioorganic & Medicinal Chemistry Letters, 1996
- Chapter 6. Thrombin and Factor Xa InhibitionPublished by Elsevier ,1996
- Stereoselective Addition of Grignard-Derived Organocopper Reagents to N-Acyliminium Ions: Synthesis of Enantiopure 5- and 4,5-Substituted ProlinatesThe Journal of Organic Chemistry, 1995
- Hirudin and Hirulog: Advances in antithrombotic therapyPerspectives in Drug Discovery and Design, 1994
- Thrombin structure and functionBlood Coagulation & Fibrinolysis, 1991
- Activation of platelets by alpha-thrombin is a receptor-mediated event. D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone-thrombin, but not N alpha-tosyl-L-lysine chloromethyl ketone-thrombin, binds to the high affinity thrombin receptor.Journal of Biological Chemistry, 1986